Florence Buseyne

Florence BUSEYNE, Research director

Immunity in Human Retroviral Infections (IHRI) group

Epidemiology and Physiopathology of Oncogenic Viruses Unit – CNRS UMR 3569

Institut Pasteur

Paris

France

Born August 31, 1966, at Dunkerque (France)

Tel: 33 1 45 68 88 99,

florence.buseyne@pasteur.fr

http://orcid.org/0000-0002-9323-7837

https://research.pasteur.fr/en/member/florence-buseyne/

EDUCATION

1984-Baccalaureate, Lycée Louis-le-Grand, Paris

1986-Classe préparatoire  MatSupBio, Lycée Henri-IV, Paris

1989-Diplôme d’agronomie approfondie, Institut National Agronomique Paris-Grignon

1994-PhD, Microbiology, Institut National Agronomique Paris-Grignon

2010-Acreditation to direct research, Université Paris-Diderot

RESEARCH AND PROFESSIONAL EXPERIENCE

1989-1992 Contract research fellow, Institut National recherche Agronomique, Jouy en Josas

1992-1994 Post-doctoral fellow, Institut Pasteur, Paris

1995-2000 Research assistant, Institut Pasteur, Paris

2001-2017 Assistant professor, Institut Pasteur, Paris

2018-current Research Director, Institut Pasteur, Paris

2015-current Group Leader

SCIENTIFIC ACTIVITIES

48 peer-reviewed articles, 11 reviews, 14 invited communications, H index: 21.

1 patent

Scientific coordinator of ANRS-EP38-IMMIP (2007-2013) and ANRS-EP59-CLEAC (2016-2023) studies.

Co-investigator of the ANRS-12414-PEDIACAM-NEG study (2020-ongoing)

Co-investigator of the ANRS MIND study (2022 ongoing)

Coordinator of the Transversal Research Program PTR 2013-437, Institut Pasteur.

Joint principal investigator, REEMFOAMY project, 2015-2019 Agence nationale de la recherche.

Coordinator of the Transversal Research Program PTR 2020-353, Institut Pasteur.

Co-investigator of Intra-Labex grant IBEID 2021-2023, Labex IBEID

PI of the ANR FURTHEST project (2024-2027)

Organizer of the 11^th international meeting on Foamy viruses, In Paris, June 2016.

TEACHING ACTIVITIES

Supervision: 2 PhD students, 2 post-doctoral fellows, 9 Master2 fellows

Participation in PhD defenses, HDR defenses,

Teaching in Master 2 courses

EXPERTISE

Reviewer for AIDS, Retrovirology, BMC journals, PLoS journals, Viruses, Intervirology, Frontiers in Immunology…

Grant reviews

Member of clinical trial committee, ANRS

Member of scientists’ evaluation committee, Institut Pasteur

Scientist in charge of the fundamental research among the coordinated action group ‘Mother and Child Health’ from ANRS-MIE

OTHER RESPONSABILITIES

Scientist in charge of BLS2 and BSL3 laboratories, since 2010

Scientist in charge of Human Biological collection since 2010

MAIN RESEARCH FUNDING OVER THE LAST 6 YEARS

2015-2018 REEMFOAMY project, Agence Nationale de la recherche, Human infection with zoonotic foamy retroviruses: role of virological and immunological factors involved in the restriction of viral emergence, € 325, 000.

2016-2017 ANRS-EP59-CLEAC, Comparison of Late and Early Antiretrovrial therapy in HIV-infected children, € 89,000.

2019-2021 ANRS-EP59-CLEAC-II study, Comparison of Late and Early Antiretroviral therapy in HIV-infected Children: impact on T cell function, activation and integrated viral DNA (CLEAC) €151,000

2023-2024 ANRS-12414-PEDIACAM-NEG study, Negative HIV-serology by immunoenzymatic test (EIA) in early treated HIV-children infected in the ANRS-Pediacam study: pathophysiological mechanisms €68,500

2020-2023 PTR program, Institut Pasteur, ZOOFOAMENV – Host pathogens interactions in humans infected with zoonotic foamy viruses, € 250,000.

2021-2024 LabEx IBEID, IntraLabex Grants, Foamy virus Env protein – where virus meets cells and host immune system, € 250,000.

2022 FRM, Doctoral grant (4^th year), Human infection with zoonotic Simian Foamy Retroviruses (SFVs) – Role of immunological factors in restricting viral emergence: Characterization of neutralizing SFV-specific antibodies, € 32,600.

2023-2024 ANRS-MIND study “MetaboImmunoNeuroDevelopement” € 29,300

2024-2027 FURTHEST project Agence Nationale de la recherche Unraveling the Foamy Virus interactions with the host: insights into the molecular mechanisms of entry and neutralization, € 262, 300

PEER-REVIEWED PUBLICATIONS

1. Buseyne, F., S. Blanche, D. Schmitt, C. Griscelli, and Y. Riviere, Detection of HIV-specific cell-mediated cytotoxicity in the peripheral blood from infected children. J Immunol, 1993. 150: p. 3569-81. 8096852
2. Buseyne, F., M. McChesney, F. Porrot, S. Kovarik, B. Guy, and Y. Riviere, Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. J Virol, 1993. 67: p. 694-702. 7678303
3. Robertson, M.N., F. Buseyne, O. Schwartz, and Y. Riviere, Efficient antigen presentation to cytotoxic T lymphocytes by cells transduced with a retroviral vector expressing the HIV-1 Nef protein. AIDS Res Hum Retroviruses, 1993. 9: p. 1217-23. 10.1089/aid.1993.9.1217. 7511396
4. Buseyne, F., G. Janvier, B. Fleury, D. Schmidt, and Y. Riviere, Multispecific and heterogeneous recognition of the gag protein by cytotoxic T lymphocytes (CTL) from HIV-infected patients: factors other than the MHC control the epitopic specificities. Clin Exp Immunol, 1994. 97: p. 353-60. 7521806
5. Robertson, M.N., F. Buseyne, M.P. Kieny, and Y. Riviere, Strain specificity of cell-mediated cytotoxic responses specific for the human immunodeficiency virus type 1 (HIV-1) envelope protein in seropositive donors: HIV-1Lai is more commonly recognized than HIV-1MN. J Infect Dis, 1994. 169: p. 274-80. 7906289
6. Buseyne, F., M. Fevrier, S. Garcia, M.L. Gougeon, and Y. Riviere, Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells. Virology, 1996. 225: p. 248-53. 10.1006/viro.1996.0597. 8918556
7. Fleury, B., G. Janvier, G. Pialoux, F. Buseyne, M.N. Robertson, J. Tartaglia, E. Paoletti, M.P. Kieny, J.L. Excler, and Y. Riviere, Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp160 of HIV-1 and boosted with a recombinant gp160. J Infect Dis, 1996. 174: p. 734-8. 8843210
8. Buseyne, F., S. Stevanovic, H.G. Rammensee, and Y. Riviere, Characterization of an HIV-1 p24gag epitope recognized by a CD8+ cytotoxic T-cell clone. Immunol Lett, 1997. 55: p. 145-9. 9161880
9. Buseyne, F., M. Burgard, J.P. Teglas, E. Bui, C. Rouzioux, M.J. Mayaux, S. Blanche, and Y. Riviere, Early HIV-specific cytotoxic T lymphocytes and disease progression in children born to HIV-infected mothers. AIDS Res Hum Retrovir, 1998. 14: p. 1435-44. 10.1089/aid.1998.14.1435. 9824321
10. Buseyne, F., G. Janvier, J.P. Teglas, S. Ivanoff, M. Burgard, E. Bui, M.J. Mayaux, S. Blanche, C. Rouzioux, and Y. Riviere, Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age. J Infect Dis, 1998. 178: p. 1019-23. 9806029
11. Buseyne, F., M.L. Chaix, B. Fleury, O. Manigart, M. Burgard, S. Blanche, C. Rouzioux, and Y. Riviere, Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children. Virology, 1998. 250: p. 316-24. 10.1006/viro.1998.9373. 9792842
12. Le Gall, S., F. Buseyne, A. Trocha, B.D. Walker, J.M. Heard, and O. Schwartz, Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J Virol, 2000. 74: p. 9256-66. 10982373
13. Buseyne, F., S. Le Gall, C. Boccaccio, J.P. Abastado, J.D. Lifson, L.O. Arthur, Y. Riviere, J.M. Heard, and O. Schwartz, MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med, 2001. 7: p. 344-9. 10.1038/85493. 11231634
14. Buseyne, F. and Y. Riviere, The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes. Int Immunol, 2001. 13: p. 941-50. 11431424
15. Buseyne, F., M.L. Chaix, C. Rouzioux, S. Blanche, and Y. Riviere, Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children. J Virol, 2001. 75: p. 4941-6. 10.1128/jvi.75.10.4941-4946.2001. 11312369
16. Firat, H., S. Tourdot, A. Ureta-Vidal, A. Scardino, A. Suhrbier, F. Buseyne, Y. Riviere, O. Danos, M.L. Michel, K. Kosmatopoulos, and F.A. Lemonnier, Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol, 2001. 31: p. 3064-74. 10.1002/1521-4141(2001010)31:10<3064::aid-immu3064>3.0.co;2-l. 11592083
17. Petit, C., F. Buseyne, C. Boccaccio, J.P. Abastado, J.M. Heard, and O. Schwartz, Nef is required for efficient HIV-1 replication in cocultures of dendritic cells and lymphocytes. Virology, 2001. 286: p. 225-36. 10.1006/viro.2001.0984. 11448175
18. Scott-Algara, D., F. Buseyne, S. Blanche, C. Rouzioux, C. Jouanne, F. Romagne, and Y. Riviere, Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers. J Infect Dis, 2001. 183: p. 1565-73. 10.1086/320708. 11343205
19. Buseyne, F., D. Scott-Algara, F. Porrot, B. Corre, N. Bellal, M. Burgard, C. Rouzioux, S. Blanche, and Y. Riviere, Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load. J Virol, 2002. 76: p. 12414-22. 12438567
20. Buseyne, F., J. Le Chenadec, B. Corre, F. Porrot, M. Burgard, C. Rouzioux, S. Blanche, M.J. Mayaux, and Y. Riviere, Inverse correlation between memory Gag-specific cytotoxic T lymphocytes and viral replication in human immunodeficiency virus-infected children. J Infect Dis, 2002. 186: p. 1589-96. 10.1086/345482. 12447734
21. Moris, A., C. Nobile, F. Buseyne, F. Porrot, J.P. Abastado, and O. Schwartz, DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood, 2004. 103: p. 2648-54. 10.1182/blood-2003-07-2532. 14576049
22. Buseyne, F., J. Le Chenadec, M. Burgard, N. Bellal, M.J. Mayaux, C. Rouzioux, Y. Riviere, and S. Blanche, In HIV type 1-infected children cytotoxic T lymphocyte responses are associated with greater reduction of viremia under antiretroviral therapy. AIDS Res Hum Retroviruses, 2005. 21: p. 719-27. 10.1089/aid.2005.21.719. 16131312
23. Buseyne, F., A. Catteau, D. Scott-Algara, B. Corre, F. Porrot, C. Rouzioux, S. Blanche, and Y. Riviere, A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children. J Immunol Methods, 2005. 298: p. 105-18. 10.1016/j.jim.2005.01.003. 15847801
24. Buseyne, F., D. Scott-Algara, N. Bellal, M. Burgard, C. Rouzioux, S. Blanche, and Y. Riviere, The frequency of HIV-specific interferon-gamma-producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children. J Infect Dis, 2005. 192: p. 1781-6. 10.1086/497152. 16235177
25. Scott-Algara, D., F. Buseyne, F. Porrot, B. Corre, N. Bellal, C. Rouzioux, S. Blanche, and Y. Riviere, Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children. J Clin Immunol, 2005. 25: p. 57-67. 10.1007/s10875-005-0358-3. 15742158
26. Buseyne, F., D. Scott-Algara, B. Corre, F. Porrot, E. Monchatre, N. Bellal, M. Burgard, C. Rouzioux, S. Blanche, and Y. Riviere, Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: Impact of age. Virology, 2006. 354: p. 271-279. CCC:000241509800005
27. Delaugerre, C., J. Warszawski, M.L. Chaix, F. Veber, E. Macassa, F. Buseyne, C. Rouzioux, and S. Blanche, Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children. J Med Virol, 2007. 79: p. 1261-9. 10.1002/jmv.20940. 17607781
28. Scott-Algara, D., C. Rouzioux, S. Blanche, M. Burgard, C. Didier, Y. Riviere, and F. Buseyne, In untreated HIV-1-infected children, PBMC-associated HIV DNA levels and cell-free HIV RNA levels are correlated to distinct T-lymphocyte populations. J Acquir Immune Defic Syndr, 2010. 53: p. 553-63. 10.1097/QAI.0b013e3181cf060f. 20142750
29. Avettand-Fenoel, V., S. Blanche, J. Le Chenadec, D. Scott-Algara, C. Dollfus, J.P. Viard, N. Bouallag, Y. Benmebarek, Y. Riviere, J. Warszawski, C. Rouzioux, and F. Buseyne, Relationships between HIV disease history and blood HIV-1 DNA load in perinatally infected adolescents and young adults: the ANRS-EP38-IMMIP study. J Infect Dis, 2012. 205: p. 1520-8. 10.1093/infdis/jis233. 22427678
30. Blanche, S., D. Scott-Algara, J. Le Chenadec, C. Didier, T. Montange, V. Avettand-Fenoel, C. Rouzioux, A. Melard, J.P. Viard, C. Dollfus, N. Bouallag, J. Warszawski, and F. Buseyne, Naive T lymphocytes and recent thymic emigrants are associated with HIV-1 disease history in french adolescents and young adults infected in the perinatal period: the ANRS-EP38-IMMIP study. Clin Infect Dis, 2014. 58: p. 573-87. 10.1093/cid/cit729. 24253249
31. Rua, R., E. Betsem, T. Montange, F. Buseyne, and A. Gessain, In vivo cellular tropism of gorilla simian foamy virus in blood of infected humans. J Virol, 2014. 88: p. 13429-35. 10.1128/jvi.01801-14. 25210185
32. Richard, L., R. Rua, E. Betsem, A. Mouinga-Ondeme, M. Kazanji, E. Leroy, R. Njouom, F. Buseyne, P.V. Afonso, and A. Gessain, Cocirculation of two env molecular variants, of possible recombinant origin, in gorilla and chimpanzee simian foamy virus strains from Central Africa. J Virol, 2015. 89: p. 12480-91. 10.1128/jvi.01798-15. 26446599
33. Le Chenadec, J., D. Scott-Algara, S. Blanche, C. Didier, T. Montange, J.P. Viard, C. Dollfus, V. Avettand-Fenoel, C. Rouzioux, J. Warszawski, and F. Buseyne, Gag-specific CD4 and CD8 T-cell proliferation in adolescents and young adults with perinatally acquired HIV-1 infection is associated with ethnicity – The ANRS-EP38-IMMIP Study. PloS One, 2015. 10: p. e0144706. 10.1371/journal.pone.0144706. 26650393
34. Lambert, C., R. Rua, A. Gessain, and F. Buseyne, A new sensitive indicator cell line reveals cross-transactivation of the viral LTR by gorilla and chimpanzee simian foamy viruses. Virology, 2016. 496: p. 219-26. 10.1016/j.virol.2016.06.010. 27348053
35. Scott-Algara, D., J. Warszawski, J. Le Chenadec, C. Didier, T. Montange, J.P. Viard, C. Dollfus, V. Avettand-Fenoel, C. Rouzioux, S. Blanche, and F. Buseyne, Gag-specific CD4 T-cell proliferation, plasmacytoid dendritic cells, and ethnicity in perinatally HIV-1-infected youths: The ANRS-EP38-IMMIP Study. AIDS Res Hum Retroviruses, 2017. 33: p. 21-28. 10.1089/aid.2016.0177. 27627837
36. Warszawski, J., V. Avettand-Fenoel, C. Rouzioux, D. Scott-Algara, T. Montange, C. Didier, J. Le Chenadec, J.P. Viard, C. Dollfus, S. Blanche, and F. Buseyne, Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-beta and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP Study. Open forum infectious diseases, 2017. 4: p. ofw239. 10.1093/ofid/ofw239. 28480237
37. Lambert, C., M. Couteaudier, J. Gouzil, L. Richard, T. Montange, E. Betsem, R. Rua, J. Tobaly-Tapiero, D. Lindemann, R. Njouom, A. Mouinga-Ondeme, A. Gessain, and F. Buseyne, Potent neutralizing antibodies in humans infected with zoonotic simian foamy viruses target conserved epitopes located in the dimorphic domain of the surface envelope protein. PLoS Pathog, 2018. 14: p. e1007293. 10.1371/journal.ppat.1007293. 30296302
38. Buseyne, F., E. Betsem, T. Montange, R. Njouom, C. Bilounga Ndongo, O. Hermine, and A. Gessain, Clinical signs and blood test results among humans infected with zoonotic simian foamy virus: a case-control study. J Infect Dis, 2018. 218: p. 144-151. 10.1093/infdis/jiy181.
39. Khan, A.S., J. Bodem, F. Buseyne, A. Gessain, W. Johnson, J.H. Kuhn, J. Kuzmak, D. Lindemann, M.L. Linial, M. Löchelt, M. Materniak-Kornas, M.A. Soares, and W.M. Switzer, Spumaretroviruses: Updated taxonomy and nomenclature. Virology, 2018. 516: p. 158-164. 10.1016/j.virol.2017.12.035. 29407373
40. Paris, J., J. Tobaly-Tapiero, M.L. Giron, J. Burlaud-Gaillard, F. Buseyne, P. Roingeard, P. Lesage, A. Zamborlini, and A. Saib, The invariant arginine within the chromatin-binding motif regulates both nucleolar localization and chromatin binding of Foamy virus Gag. Retrovirology, 2018. 15. 10.1186/s12977-018-0428-z. 29996845
41. Lambert, C., D. Batalie, T. Montange, E. Betsem, A. Mouinga-Ondeme, R. Njouom, A. Gessain, and F. Buseyne, An immunodominant and conserved B-cell epitope in the envelope of simian foamy virus recognized by humans infected with zoonotic strains from apes. J Virol, 2019. 93: p. e00068-19. 10.1128/jvi.00068-19. 30894477
42. Gessain , A., T. Montange, E. Betsem, C. Bilounga Ndongo, R. Njouom, and F. Buseyne, Case-control study of immune status in humans infected with zoonotic gorilla simian foamy viruses. J Infect Dis, 2020. 221: p. 1724-1733. doi.org/10.1093/infdis/jiz660. 31822908
43. Couteaudier, M., D. Calzada-Fraile, T. Montange, A. Gessain , and F. Buseyne, Inhibitors of the interferon response increase the replication of gorilla simian foamy viruses. Virology, 2020. 541: p. 25-31. 10.1016/j.virol.2019.11.019. 31826843
44. Avettand-Fenoel, V., J. Le Chenadec, M. Diallo, M. Fillion, A. Mélard, C. Dollfus, S. Blanche, A. Faye, K. Amokrane, B. Autran, F. Buseyne, J. Warszawski, P. Frange, and for the ANRS-EP59-CLEAC study group, Initiating antiretroviral treatment early in infancy has long-term benefits on the HIV reservoir in late childhood and adolescence. Clin Infect Dis, 2021. aop. doi: 10.1093/cid/ciaa1931.
45. Frange P, Montange T, Le Chenadec JM, Batalie D, Fert I, Dollfus C, Faye A, Blanche S, Chace A, Fourcade C, Hau I, Levine M, Mahlaoui N, Marcou V, Tabone MD, Veber F, Hoctin A, Wack T, Avettand-Fenoel V, Warszawski J, Buseyne F. Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study. Frontiers in Immunology. 2021; 12:662894. doi: 10.3389/fimmu.2021.662894
46. Couteaudier M, Montange T, Njouom R, Bilounga-Ndongo B, Gessain A and BUSEYNE F. Plasma antibodies from humans infected with zoonotic simian foamy virus do not inhibit cell-to-cell transmission of the virus despite binding to the surface of infected cells. PLoS Pathog. 2022; 18:e1010470. doi: 10.1371/journal.ppat.1010470
47. Dynesen LT, Fernandez I, Coquin Y, Delaplace M, Montange T, Njouom R, Bilounga-Ndongo C, Rey FR, Gessain A, Backovic M, and BUSEYNE F, Neutralization of zoonotic simian foamy viruses: genotype-specific epitopes within the receptor binding domain. PLoS Pathog., 2023. 19: e1011339. doi: 10.1371/journal.ppat.1011339
48. Fernandez I, Dynesen LT, Coquin Y, Pederzoli R, Brun D, Haouz A, Gessain A, Rey FR, BUSEYNE F, and Backovic M, The crystal structure of a simian foamy virus receptor binding domain provides clues on the entry to host cells. Nat. Comm., 2023. 14: 1262. doi: 10.1038/s41467-023-36923-0

REVIEWS

44. Buseyne, F., M. McChesney, F. Tanneau, L. Montagnier, and Y. Rivière, Characterization of the cytotoxic immune response to the Human Immunodeficiency Virus, HIV-1., in Cytotoxic T cells in HIV and other retroviral infections, P. Racz, N. Letvin, and J.C. Gluckman, Editors. 1992, Karger: Basel. p. 81-85.
45. Buseyne, F. and Y. Riviere, HIV-specific CD8+ T-cell immune responses and viral replication. AIDS, 1993. 7 Suppl 2: p. S81-5. 7909230
46. Riviere, Y., M.N. Robertson, and F. Buseyne, Cytotoxic T lymphocytes in human immunodeficiency virus infection: regulator genes. Curr Top Microbiol Immunol, 1994. 189: p. 65-74. 7924437
47. Rivière, Y. and F. Buseyne, Spécificité du déficit immunitaire chez l’enfant infecté par le VIH par la voie materno-foetale, in Infection à VIH de la mère et de l’enfant, Flammarion, Editor. 1998: Paris. p. 97-107.
48. Riviere, Y. and F. Buseyne, Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV. Vaccine, 1998. 16: p. 1420-1422.
49. Rivière, Y., F. Buseyne, and D. Scott-Algara, Les outils de l’exploration de l’activité des lymphocytes T CD8+. Virologie, 2000. 4: p. 463-471.
50. Materniak, M., P. Kubis, M. Rola-Luszczak, A.S. Khan, F. Buseyne, D. Lindemann, M. Lochelt, and J. Kuzmak, Tenth International Foamy Virus Conference 2014–achievements and perspectives. Viruses, 2015. 7: p. 1651-66. 10.3390/v7041651. 25835535
51. Frange, P., V. Avettand-Fenoel, and F. Buseyne, Traitement précoce des nourrissons infectés par le VIH-1. MedTher Pediat, 2016. 19: p. 59-66. 10.1684/mtp.2016.0581.
52. Buseyne, F., A. Gessain, M.A. Soares, A.F. Santos, M. Materniak-Kornas, P. Lesage, A. Zamborlini, M. Lochelt, W. Qiao, D. Lindemann, B.M. Wohrl, J.P. Stoye, I.A. Taylor, and A.S. Khan, Eleventh International Foamy Virus Conference-Meeting Report. Viruses, 2016. 8: p. E318. 10.3390/v8110318. 27886074
53. Buseyne, F., L’infection zoonotique par les virus foamy simiens : une réponse anticorps puissante. Virologie, 2019. 31131828
54. Buseyne, F., Zoonotic foamy viruses: first medical study of infected people. M S-Med Sci, 2019. 35: p. 298-301. 10.1051/medsci/2019061. 31038105
55. Herchenroder, O., M. Lochelt, F. Buseyne, A. Gessain, M.A. Soares, A.S. Khan, and D. Lindemann, Twelfth International Foamy Virus Conference-Meeting Report. Viruses, 2019. 11. 10.3390/v11020134. 30717288